Fidia's HYMOVIS Receives Product-Specific J-Code
The U.S. Center for Medicare & Medicaid Services (CMS) assigned a unique Healthcare Common Procedure Coding System (HCPCS) code or J-Code to Fidia Pharma's HYMOVIS® highly viscoelastic, non-crosslinked hydrogel to treat knee osteoarthritis pain. The reimbursement code is effective January 2017.
The product was launched in the U.S. at AAOS 2016.
Other viscosupplements in 2016 news include:
Sources: Fidia Pharma USA Inc.; ORTHOWORLD Inc.